Vaccination against Clostridium perfringens type C enteritis in pigs: a field study using an adapted vaccination scheme Original paper

What was studied?

This field study evaluated the effectiveness of vaccination against Clostridium perfringens type C in preventing necrotizing enteritis in piglets by measuring neutralizing antibody responses in vaccinated sows and their offspring. Researchers assessed antibody production against beta toxin (CPB), the primary virulence factor responsible for microbiome-mediated intestinal necrosis. They compared standard vaccination protocols with an adapted vaccination schedule that included additional booster doses. The study measured neutralizing anti-CPB antibody titers in sow serum, colostrum, milk, and piglet serum to determine the efficiency of passive immunity transfer through the maternal microbiome-host interface. The investigation confirmed that protective immunity depends on sufficient neutralizing antibody production and successful transfer through colostrum following vaccination.

Who was studied?

The study examined vaccinated gilts, multiparous sows, and their neonatal piglets from multiple pig breeding farms with established microbiome exposure to Clostridium perfringens type C. Researchers analyzed serum and colostrum antibody levels in vaccinated animals and measured passive antibody transfer to piglets. These animals represented populations at risk for microbiome-driven necrotizing enteritis, where early-life colonization by toxin-producing Clostridium perfringens can lead to severe intestinal disease and mortality if protective antibodies are insufficient.

What were the most important findings?

The most important finding was that protective immunity against Clostridium perfringens type C depends on the production and transfer of neutralizing antibodies targeting beta toxin, which represents a key microbiome virulence factor. Major microbial associations included beta toxin-mediated intestinal damage, microbiome colonization risk, and antibody-mediated toxin neutralization. Multiparous sows that received booster vaccinations developed significantly higher neutralizing anti-CPB antibody titers in serum, colostrum, and milk compared to gilts, resulting in higher antibody levels in piglets.

Colostral antibody levels strongly correlated with piglet serum antibody titers, confirming that maternal antibody transfer directly determines microbiome infection resistance. In contrast, gilts often produced low or undetectable antibody levels under standard vaccination protocols, leaving piglets vulnerable to microbiome-driven pathogen expansion. The adapted vaccination protocol using three injections instead of two significantly increased antibody titers in gilts and their piglets, improving passive immunity. These findings confirmed that neutralizing antibodies directly prevent toxin-mediated endothelial damage and intestinal necrosis by blocking beta toxin activity.

What are the greatest implications of this study/review?

This study demonstrated that microbiome-mediated Clostridium perfringens infection risk is strongly determined by neutralizing antibody protection against beta toxin. Adequate maternal vaccination ensures sufficient passive immunity transfer to protect neonates from toxin-producing microbiome pathogens. Optimizing vaccination protocols improves microbiome stability and prevents toxin-mediated intestinal disease. These findings identify antibody titers as a key microbiome signature of protection and support targeted immunization strategies to prevent pathogen-driven dysbiosis and necrotizing enteritis.